Age (years±SD) | 56.61±11.19 | 56.51±11.58 | 56.68±11 | 55.19±10.8 | 57.2±10.98 | 0.59 |
Gender (F/M)(%) | 119/121 (49.6/50.4) | 90/86 (51.1/48.9) | 10/8 (55.5/44.4) | 15/17 (46.9/53.1) | 4/10 (28.6/71.4) | 0.34 |
Body mass index (kg/m2) | 26.89±4.07 | 27.14±3.72 | 25.72±3.56 | 25.21±2.9 | 26.51±3.49 | 0.13 |
Inflammation | 138/102 (57.5/42.5%) | 86/90 (48.9/51.1%) | 18/0 (100/0%) | 20/12 (62.5/37.5%) | 14/0 (100/0%) | <0.001 |
Activity (+/−) | 154/86 (64.2/35.8%) | 96/80 (54.5/45.5%) | 18/0 (100/0%) | 26/6 (81.2/18.8%) | 14/0 (100/0%) | <0.001 |
Intestinal metaplasia (+/−) | 145/95 (60.4/39.6%) | 83/93 (47.2/52.8%) | 18/0 (100/0%) | 30/2 (93.8/6.3%) | 14/0 (100/0%) | <0.001 |
Lower gastrointestinal symptom/iron deficiency | 151/89 (62.9/37.1%) | 125/51 (71/39%) | 4/14 (22.2/77.8%) | 14/18 (43.8/56.3%) | 8/6 (57.1/42.9%) | 0.25 |
APCA (+/−) | 196/44 (81.7/18.3%) | 143/33 (81.2/18.8%) | 15/3 (83.3/16.7%) | 26/6 (81.3/18.7%) | 12/2 (85.7/14.3%) | 0.19 |
Vitamin B12 (pg/L) (median) | 188 (105–850) | 199 (165–850) | 187 (170–430) | 189 (172–530) | 186 (105–390) | 0.12 |
Chromogranin A (ng/mL) (min-max) | 268.37±163.68 | 178.12±68.21 | 430.21±55.87 | 368.25±51.62 | 635.68±84.1 | 0.001 |
Gastrin (pg/mL) (min-max) | 592.95±223.34 | 430.6±199.25 | 712.31±131.52 | 654.28±104.41 | 992.78±249.88 | 0.001 |